Which treatment for high-risk patients with DLBCL?

被引：0
|
作者：
Coiffier, Bertrand [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Hosp Civils Lyon, F-69310 Pierre Benite, France
来源：
LANCET ONCOLOGY | 2012年 / 13卷 / 12期
关键词：
HIGH-DOSE CHEMOTHERAPY; B-CELL LYMPHOMA; OPEN-LABEL; CHOP CHEMOTHERAPY; YOUNG-PATIENTS; PHASE-3; TRIAL; RITUXIMAB; DSHNHL;
D O I：
10.1016/S1470-2045(12)70507-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1180 / 1182
页数：4
相关论文
共 50 条
  • [1] Therapeutic strategies in high-risk DLBCL patients
    Viardot, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 42 - 42
  • [2] Treatment of patients with high risk DLBCL
    Keller, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 22 - 22
  • [3] Pancreatoduodenectomy for Malignancy: Which Patients Are High-Risk?
    Russell, T.
    Labib, P.
    Aroori, S.
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [4] Which Patients Are Persistently High-Risk for Hospitalization?
    Chang, Evelyn T.
    Piegari, Rebecca
    Wong, Edwin S.
    Rosland, Ann-Marie
    Fihn, Stephan D.
    Vijan, Sandeep
    Yoon, Jean
    AMERICAN JOURNAL OF MANAGED CARE, 2019, 25 (09): : E274 - +
  • [5] High-risk DLBCL: interim PET? Not yet
    Hertzberg, Mark
    BLOOD, 2017, 130 (11) : 1277 - 1278
  • [6] CSF IGH REARRANGEMENT IN HIGH-RISK DLBCL PATIENTS TREATED WITH INTRATHECAL PROPHYLAXIS
    Tisi, M. C.
    D'Alo, F.
    Bellesi, S.
    Maiolo, E.
    Alma, E.
    Cuccaro, A.
    Chiusolo, P.
    Voso, M. T.
    Hohaus, S.
    HAEMATOLOGICA, 2016, 101 : 819 - 820
  • [7] Prognostic analysis of DLBCL patients and the role of upfront ASCT in high-intermediate and high-risk patients
    Zhao, Ying
    Wang, Hong
    Jin, Song
    Zheng, Jiajia
    Huang, Man
    Tang, Yaqiong
    Jin, Zhengming
    Qiu, Huiying
    Tang, Xiaowen
    Fu, Chengcheng
    Han, Yue
    Wu, De-Pei
    ONCOTARGET, 2017, 8 (42) : 73168 - 73176
  • [8] Osteoporosis: treatment of high-risk patients
    Schmidmaier, Ralf
    ORTHOPADIE, 2023, 52 (10): : 799 - 807
  • [9] TREATMENT OF INFECTIOUS AND HIGH-RISK PATIENTS
    COWLING, RD
    BRITISH DENTAL JOURNAL, 1988, 164 (08) : 238 - 238
  • [10] New high-risk molecular subtypes of DLBCL identified
    David Killock
    Nature Reviews Clinical Oncology, 2019, 16 : 68 - 68
12345